Fund Holdings — ORACLE INVESTMENT MANAGEMENT INC

Total Portfolio Value:
$115.55M
Total Bought:
$6.51M
Total Sold:
$32.22M
Net Transaction:
-$25.71M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
GeneDx Holdings Corp.CL A(WGS)969,954922,454-47,500$85.90M$85.15M73.69%-$752.2K
Biohaven Ltd.(BHVN)665,945673,166+7,221$16.01M$9.50M8.22%-$6.51M
Ardelyx Inc2,404,4381,430,728-973,710$11.81M$5.61M4.85%-$6.20M
Palantir Technologies Inc.CL A(PLTR)29,50029,5000$2.49M$4.02M3.48%+$1.53M
QuidelOrtho Corporation(QDEL)118,291118,2910$4.14M$3.41M2.95%-$727.5K
Teladoc Health, Inc.(TDOC)565,900381,000-184,900$4.50M$3.32M2.87%-$1.19M
Forian Inc
COM
1,366,1071,366,1070$2.73M$2.68M2.32%-$54.6K
CAVA Group, Inc.(CAVA)18,60018,6000$1.61M$1.57M1.36%-$40.5K
Biogen Inc.(BIIB)2,4122,4120$330.1K$302.9K0.26%-$27.1K
Recursion Pharmaceuticals, Inc.CL A(RXRX)120,0000-120,000$634.8K$0—-$634.8K
Springworks Therapeutics Inc531,3510-531,351$23.45M$0—-$23.45M
Page 1 of 1
ORACLE INVESTMENT MANAGEMENT INC — 13F Holdings — Q2 2025 | TickerTrail